Maths statistics biology physics chemistry bioinformatics. Saturday, February 6, 2010. Choosing between academia and industry. 7Plan for the long term. But get impressions; record everything. Down to your gut feelings. Monday, November 23, 2009.

Drug Discovery Informatics your whole Project Team will embrace. Store and organize your data. Plot datasets and mine them. Redbrick Molecular Selects CDD Vault to Manage Diverse Medicinal Chemistry Catalogs. We had Excel sheets all over the place and data from different projects that were just separated in different folders and after a while, it got to the.

The focus of this blog is molecular design which can be defined as control of the behavior of compounds and materials by manipulation of molecular properties. Sometimes vampires get staked and soucouyants get salted. Facebook FBDD and Molecular Design Group.

Institute of Biochemistry and Molecular Medicine, University of Bern, Switzerland. Please Click on our Laboratory Homepage. Institute of Biochemistry and Molecular Medicine, University of Bern, Switzerland. Room 322, Bühlstrasse 28, CH-3012 Bern, Switzerland. Map and Directions PLEASE click above. Our new labs are at the Getrud Wolker Strasse 5, in walking distance of the IBMM entrance - please report at the IBMM main entrance.

Improving Solubility using X-ray crystal structure data. From AstraZeneca provides a really interesting overview of the approach that they took to optimise the solubility of a series of GPR119 agonists. The initial lead compound 2. A clinical candidate for treating type II diabetes. The paper also serves to illustrate and build upon the concepts described in the review that we blogged.

This is a work of fiction. If you find any resemblance to actual persons, living or dead, or actual events, deadly or lively, or actual molecules, carbons or heteroatoms, it is purely coincidental. At this time my father became critically ill, I had to go .

Medicinal, Chemistry and Biochemistry blog from the Sussex Drug Discovery Centre. Toward a future of truly personalized cancer therapy. Targeted cancer therapies have produced substantial clinical results in the last decade, but most tumours eventually develop resistance to these drugs. Benes, Engelman and colleagues have recently described in.